DCTH (Delcath Systems, Inc.) Stock Financials & Earnings | Market Cap Arena

DCTH (Delcath Systems, Inc.) Stock Financials & Earnings | Market Cap Arena

DCTHDelcath Systems, Inc.

Mkt Cap$329M

Healthcare·Medical - Devices·🇺🇸 United States·NASDAQ

Revenue (TTM)$85M

Net Income (TTM)$3M

EPS (TTM)$0.06

Free Cash Flow (TTM)$21M

Gross Margin86.2%

Op. Margin0.8%

Net Margin3.2%

FCF Margin24.6%

P/S Ratio (TTM)3.9x

P/E Ratio (TTM)121.9x

YoY Rev Growth+129.1%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$597K	$416K	-$8M
Q2 23	$495K	$345K	-$8M
Q3 23	$434K	$301K	-$11M
Q4 23	$539K	$368K	-$11M
Q1 24	$3M	$2M	-$10M
Q2 24	$8M	$6M	-$4M
Q3 24	$11M	$10M	-$1M
Q4 24	$15M	$13M	$3M
Q1 25	$20M	$17M	$642K
Q2 25	$24M	$21M	$3M
Q3 25	$21M	$18M	-$388K
Q4 25	$21M	$18M	-$2M

Valuation

Quarter	P/S	P/E
Q1 23	112.0x	—
Q2 23	124.8x	—
Q3 23	152.0x	—
Q4 23	159.3x	—
Q1 24	71.4x	—
Q2 24	27.7x	—
Q3 24	14.5x	—
Q4 24	8.8x	—
Q1 25	6.1x	—
Q2 25	4.7x	147.4x
Q3 25	4.1x	274.7x
Q4 25	3.9x	121.9x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 23	-$4M	-$4M
Q2 23	-$10M	-$10M
Q3 23	-$9M	-$9M
Q4 23	-$8M	-$8M
Q1 24	-$10M	-$10M
Q2 24	-$4M	-$5M
Q3 24	-$4M	-$4M
Q4 24	-$1M	-$1M
Q1 25	$2M	$2M
Q2 25	$7M	$7M
Q3 25	$5M	$4M
Q4 25	$8M	$8M

Capital Expenditures

CapEx

Quarter	CapEx
Q1 23	$0
Q2 23	$40K
Q3 23	$1K
Q4 23	$19K
Q1 24	$13K
Q2 24	$101K
Q3 24	$216K
Q4 24	$229K
Q1 25	$140K
Q2 25	$398K
Q3 25	$459K
Q4 25	$550K

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 23	+57.9%	+2.3%
Q2 23	-37.9%	-17.4%
Q3 23	-52.1%	+21.0%
Q4 23	-15.6%	+16.5%
Q1 24	+425.8%	+50.4%
Q2 24	+1468.9%	+37.5%
Q3 24	+2480.6%	+13.4%
Q4 24	+2701.5%	+1.8%
Q1 25	+530.3%	+42.7%
Q2 25	+211.0%	+84.7%
Q3 25	+83.6%	+68.2%
Q4 25	+37.3%	+90.0%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 23	$2M	278.2%
Q2 23	$2M	335.6%
Q3 23	$3M	652.1%
Q4 23	$2M	370.9%
Q1 24	$3M	93.8%
Q2 24	$3M	39.5%
Q3 24	$2M	19.1%
Q4 24	$2M	10.7%
Q1 25	$7M	34.7%
Q2 25	$7M	29.8%
Q3 25	$0	0.0%
Q4 25	$5M	21.8%

OpEx Breakdown

Quarter	R&D	SG&A
Q1 23	$5M	$4M
Q2 23	$4M	$5M
Q3 23	$5M	$6M
Q4 23	$5M	$7M
Q1 24	$4M	$9M
Q2 24	$3M	$7M
Q3 24	$4M	$7M
Q4 24	$3M	$7M
Q1 25	$5M	$11M
Q2 25	$7M	$11M
Q3 25	$8M	$10M
Q4 25	$9M	$11M

Revenue Segments

Quarter	Product
Q1 23	$597K
Q2 23	$495K
Q3 23	$434K
Q4 23	$539K

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$24M	$0	$24M
Q2 23	$15M	$0	$15M
Q3 23	$40M	$0	$40M
Q4 23	$13M	$20M	$32M
Q1 24	$12M	$15M	$27M
Q2 24	$15M	$5M	$20M
Q3 24	$8M	$6M	$14M
Q4 24	$32M	$21M	$53M
Q1 25	$13M	$46M	$59M
Q2 25	$34M	$47M	$81M
Q3 25	$42M	$47M	$89M
Q4 25	$43M	$48M	$91M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q1 23	12M	+17.7%
Q2 23	12M	+7.2%
Q3 23	18M	+43.3%
Q4 23	23M	+29.3%
Q1 24	25M	+7.8%
Q2 24	28M	+14.0%
Q3 24	32M	+14.0%
Q4 24	32M	-1.0%
Q1 25	40M	+23.4%
Q2 25	40M	+1.9%
Q3 25	40M	-0.5%
Q4 25	36M	-9.0%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 14	$43K	25
FY 15	$50K	35
FY 16	$46K	43
FY 17	$59K	46
FY 18	$79K	43
FY 19	$48K	33
FY 20	$46K	36
FY 21	$65K	55
FY 22	$52K	52
FY 23	$27K	76
FY 24	$388K	96
FY 25	$3K	34K